Cited by 339Parkinson's Disease Mechanisms and TreatmentsUbiquitin and proteasome pathwaysNuclear Receptors and Signaling

Autoregulation of Parkin activity through its ubiquitin‐like domain

Open access
Chaugule, Viduth K, Burchell, Lynn, Barber, Kathryn R, Sidhu, Ateesh, Leslie, Simon J, Shaw, Gary S, Walden, Helen·2011·The EMBO Journal

Abstract

Parkin is an E3-ubiquitin ligase belonging to the RBR (RING-InBetweenRING-RING family), and is involved in the neurodegenerative disorder Parkinson's disease. Autosomal recessive juvenile Parkinsonism, which is one of the most common familial forms of the disease, is directly linked to mutations in the parkin gene. However, the molecular mechanisms of Parkin dysfunction in the disease state remain to be established. We now demonstrate that the ubiquitin-like domain of Parkin functions to inhibit its autoubiquitination. Moreover pathogenic Parkin mutations disrupt this autoinhibition, resulting in a constitutively active molecule. In addition, we show that the mechanism of autoregulation involves ubiquitin binding by a C-terminal region of Parkin. Our observations provide important molecular insights into the underlying basis of Parkinson's disease, and in the regulation of RBR E3-ligase activity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/emboj.2011.204

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Proteasomal degradation of parkin occurs during mitophagy due to autoubiquitination, halting its activity.

    “Proteasomal degradation of parkin was demonstrated during mitophagy due to autoubiquitination, halting its activity28,29,33,34.”

    From Altered mitochondrial dynamics and function in APOE4-expressing astrocytes (2020) · cites this paper as [33]

    The Discussion (page unavailable) describes proteasomal degradation of Parkin mutants and proposes that autoubiquitination may lead to Parkin degradation and inactivation. It does not demonstrate that this occurs during mitophagy; it instead suggests that autoubiquitination and degradation of wild-type Parkin are absent or prevented in normal cellular conditions. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Hedrich K, Eskelson C, Wilmot B, Marder K, Harris J, Garrels J, Meija-Santana H, Vieregge P, Jacobs H, Bressman SB, Lang AE, Kann M, Abbruzzese G, Martinelli P, Schwinger E, Ozelius LJ, Pramstaller PP, Klein C, Kramer P (2004) Distribution, type, and origin of Parkin mutations: review and case studies. Mov Disord 19: 1146-1157

Cited by

Sorted by citations

Authors
Chaugule, V. K., Burchell, L., Barber, K. R., Sidhu, A., Leslie, S. J., Shaw, G. S., & Walden, H.
Affiliations
  • Cancer Research UK (GB)
  • Western University (CA)
Corresponding author
Walden, Helen
Venue
The EMBO Journal
Published
2011-06-21
Volume
30
Issue
14
Pages
2853-2867
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W2113440807
Cited by
339
References
5
Citations by year
2026: 12 · 2025: 15 · 2024: 24 · 2023: 27 · 2022: 16 · 2021: 22 · 2020: 23 · 2019: 14 · 2018: 23 · 2017: 22 · 2016: 28 · 2015: 33 · 2014: 28 · 2013: 27 · 2012: 19
FWCI
15.38
Type
journal article
Language
en
Open access
Locations
  • The EMBO Journal (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Discovery Research Portal (University of Dundee) (publishedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
Funders
  • Cancer Research UK
  • Canadian Institutes of Health Research
Topics
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
Keywords
Parkin, ubiquitin-like domain, autoubiquitination, autoinhibition, RBR E3 ubiquitin ligase, Parkinson's disease, autosomal recessive juvenile parkinsonism, parkin mutations, ubiquitin binding
MeSH terms
Amino Acid Sequence, Homeostasis, Humans, Molecular Sequence Data, Mutation, Parkinson Disease, Peptide Fragments, Protein Conformation, Gene Expression Regulation, Enzymologic, Sequence Homology, Amino Acid, Ubiquitin, Ubiquitin-Protein Ligases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review